Paloma Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-36,901
| Closed | -$62.7K | – | 673 |
|
|
2024
Q3 | $62.7K | Buy |
+36,901
| New | +$62.7K | ﹤0.01% | 791 |
|
|
2022
Q2 | – | Sell |
-15,186
| Closed | -$138K | – | 1104 |
|
|
2022
Q1 | $138K | Buy |
+15,186
| New | +$138K | ﹤0.01% | 1140 |
|
|
2021
Q4 | – | Sell |
-10,177
| Closed | -$260K | – | 1657 |
|
|
2021
Q3 | $260K | Buy |
+10,177
| New | +$260K | 0.01% | 651 |
|
|
2021
Q2 | – | Sell |
-15,394
| Closed | -$513K | – | 1855 |
|
|
2021
Q1 | $513K | Buy |
+15,394
| New | +$513K | 0.01% | 926 |
|
|
2020
Q2 | – | Sell |
-43,077
| Closed | -$132K | – | 1964 |
|
|
2020
Q1 | $132K | Buy |
+43,077
| New | +$132K | 0.01% | 905 |
|
|
2019
Q4 | – | Sell |
-13,644
| Closed | -$70K | – | 2015 |
|
|
2019
Q3 | $70K | Sell |
13,644
-119,285
| -90% | -$612K | ﹤0.01% | 1533 |
|
|
2019
Q2 | $804K | Sell |
132,929
-91,371
| -41% | -$553K | 0.01% | 635 |
|
|
2019
Q1 | $1.62M | Buy |
224,300
+69,200
| +45% | +$500K | 0.04% | 356 |
|
|
2018
Q4 | $1.15M | Buy |
+155,100
| New | +$1.15M | 0.04% | 297 |
|
|
2017
Q1 | – | Sell |
-26,600
| Closed | -$101K | – | 1624 |
|
|
2016
Q4 | $101K | Buy |
+26,600
| New | +$101K | ﹤0.01% | 1448 |
|
|
2015
Q1 | – | Sell |
-22,900
| Closed | -$180K | – | 1245 |
|
|
2014
Q4 | $180K | Buy |
22,900
+8,200
| +56% | +$64.5K | 0.01% | 934 |
|
|
2014
Q3 | $72K | Buy |
+14,700
| New | +$72K | ﹤0.01% | 848 |
|